Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 1/20 | 0.32 |
| ▸ | CNR2 | P34972 | 1/20 | 0.32 |
| ▸ | DAGLA | Q9Y4D2 | 1/20 | 0.32 |
| ▸ | PARP1 | P09874 | 1/20 | 0.31 |
| ▸ | ACE | P12821 | 2/20 | 0.31 |
| ▸ | PREP | P48147 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18532509 | 0.84 | PARP1 (0.43) | PARP1 | |
| SCHEMBL21100022 | 0.82 | CNR2 (0.35) | CNR2ACE | |
| SCHEMBL29484187 | 0.79 | HSD17B10 (0.52) | — | |
| SCHEMBL19658364 | 0.79 | ACE (0.35) | ACE | |
| SCHEMBL30439285 | 0.78 | PARP1 (0.39) | PARP1 | |
| SCHEMBL21100019 | 0.76 | MAPT (0.36) | CNR2 | |
| SCHEMBL22342473 | 0.75 | ALDH1A1 (0.36) | ACE | |
| SCHEMBL12658485 | 0.74 | ACE (0.53) | ACE | |
| SCHEMBL16518728 | 0.74 | ACE (0.53) | ACE | |
| SCHEMBL16743626 | 0.73 | ACE (0.37) | ACE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9572881-B2 | Halogenated compounds for photodynamic therapy | NANOQUANTUM SCIENCES, INC. (US) | 2017-02-21 | — | — | US | disclosed |
| US-20150335745-A1 | HALOGENATED COMPOUNDS FOR PHOTODYNAMIC THERAPY | NANOQUANTUM SCIENCES, INC. (US) | 2015-11-26 | — | — | US | disclosed |
| US-9040721-B2 | Halogenated compounds for Photodynamic therapy | NANOQUANTUM SCIENCES, INC. (US) | 2015-05-26 | — | — | US | disclosed |
| US-8962797-B2 | Halogenated compounds for photodynamic therapy | NANOQUANTUM SCIENCES, INC. (US) | 2015-02-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150335745-A1 | HALOGENATED COMPOUNDS FOR PHOTODYNAMIC THERAPY | PNMT, PBRM1, PAICS | CNR1 2260/4885CNR2 2794/4885DAGLA 4516/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.